“Enough time” is one of the necessary components of what it takes to be a “good” doctor. Here’s how this doctor defines “enough.”
Statins effectively lower levels of various pro-inflammatory markers of immune activation. So can statin therapy prevent CVD events in HIV-infected persons?
Details here about a quick reference guide for HIV primary care clinicians caring for HIV in older adults.
The FDA proposes to ease its lifetime ban on blood donations by men who have sex with men (MSM), but proposes to block donations by MSM within the last year. Here’s the rationale.
This AIDS specialist offers his rank-order list of the top 10 HIV clinical trials that really made a difference. The trials differ substantially in design, size, and focus, but they all were “game changers.”
If full restoration of immunologic and clinical health is the goal of antiretroviral therapy, the best chance we have is to start ART within 12 months of infection.
Increasing clinical evidence suggests that statins may help prevent cancer in certain HIV-1–infected patients. Details here.
Does the HIV epidemic represent primarily a failure of the public health system--or is it more likely a result of failure on an individual level to take steps necessary to prevent infection?
"Don't ask, don't tell" seems to apply to gay and bisexual men when it comes to discussions about HIV with their physician. Worrisome details from a new Kaiser Family Foundation survey here.
There is emergent need to improve recognition and management of COPD in HIV-infected patients. Details here.
Despite gains, the sobering reality is that HIV transmission-- primarily via sexual means--continues at an unacceptably high rate in the United States.
Now that HIV infection is largely a chronic disease, cardiovascular disease has become a leading cause of death in this patient group. Here: a look at just how common LDL-C dyslipidemia, hypertension, and coronary heart disease really are.
The flu vaccine effectively prevents influenza in pregnant women, regardless of whether they are HIV positive, according to a new study. Results offer clinicians greater assurance to vaccinate all pregnant woman.
A once daily MVC plus DRV/r regimen had an effective role in antiretroviral drug-pretreated individuals with controlled HIV infection in this trial. In an aging HIV-infected population, with increasing comorbidities, this combination could be a safer option than standard triple therapy. More here.
It now seems probable that most people with HCV infection can be cured—even if they are co-infected with HIV. But can we bear the cost?